Omkar Pharmachem stock | 2026 price target, earnings & valuation

Omkar Pharmachem

BSE:532167

Rp 28,33

Rp0,00 (0,00%)

28,33 Rp

Rp0,00 (0,00%)

End-of-day quote: 10/31/2025

Omkar Pharmachem Stock Value

Currently, analysts rate BSE:532167 as sf_Data Unavailable.

Omkar Pharmachem Company Info

EPS Growth 5Y

0,00%

Market Cap

Rp0,29 B

Long-Term Debt

Rp0,00 B

Annual earnings

05/29/2026 (E)

Dividend

Rp0,00

Dividend Yield

0,00%

Founded

1995

Industry

Industrials

Country

India

Website

Omkar Pharmachem

ISIN Number

INE501C01015

Website

http://www.omkarpharmachem.co.in

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

There are currently no price targets available for this stock.

In the last five quarters, Omkar Pharmachem’s Price Target has risen from Rp0,00 to Rp28,33 - a 100,00% increase.

Top growth stocks in the industrials sector (5Y.)

What does Omkar Pharmachem do?

Omkar Pharmachem Limited is a company engaged in the pharmaceutical sector, focusing primarily on manufacturing and distributing various chemical and pharmaceutical products. The organization has established itself within the healthcare landscape, aiming to provide high-quality products that adhere to stringent regulatory standards. Business Segments The company operates in a singular business segment, which consolidates its focus on the pharmaceutical and chemical manufacturing domain. This c...

Business Segments

The company operates in a singular business segment, which consolidates its focus on the pharmaceutical and chemical manufacturing domain. This concentrated approach allows the company to streamline its operations and enhance efficiency across its product lines.

As the company navigates a challenging economic environment, it utilizes a strategy of diversification within its singular segment to accommodate shifting market demands. This approach includes the exploration of innovative product lines, investing in R&D activities, and optimizing production capabilities to meet new therapeutic requirements.

Business Strategy

The company’s business strategy is centered around revitalization, focusing on portfolio transformation and operational efficiencies. To rejuvenate its market presence, the company is actively seeking opportunities for mergers and acquisitions, which are expected to facilitate quicker reintegration into the market landscape.

Moreover, with the contours of the market landscape shifting due to global economic uncertainties, the company is preparing itself for resilience. The company's strategy not only emphasizes growth but also encapsulates a risk management framework that identifies potential threats.

Products and Services

The company specializes in the production of a diverse array of chemical and pharmaceutical formulations. The company’s product line includes active pharmaceutical ingredients (APIs), intermediates, and specialized formulations, emphasizing quality and regulatory compliance.

Additionally, the company focuses on customizing products to meet the unique needs of its clientele, which includes healthcare professionals, hospitals, and pharmacies.

An integral part of the company’s service offering is its commitment to customer service, which includes consistent engagement with clients, prompt feedback mechanisms, and a customer-centric approach to post-sale support.

Geographical Markets Served

The company primarily serves markets within India, with aspirations to expand its geographical reach. The focus on the Indian market allows the company to leverage local industry dynamics and foster relationships within the regional healthcare ecosystem.

Customers Names

The company serves a diverse customer base that includes hospitals, pharmacies, and healthcare providers. The company boasts relationships with numerous clients across the pharmaceutical supply chain.

The customer categories served by the company encompass institutional clients, retail pharmacies, and wholesalers. Each of these segments plays a significant role in facilitating the distribution of the company products, thereby ensuring wide-reaching impact in the healthcare community.

Sales and Marketing

The company employs a multi-channel approach to sales and marketing to reach its customers effectively. This encompasses a combination of direct sales, online platforms, and traditional marketing techniques. The company places a strong emphasis on building relationships with healthcare providers and pharmacies, allowing for effective promotion and distribution of its products.

The distribution channel utilized by the company includes partnerships with wholesalers that facilitate broader market access and retail pharmacy chains that ensure easy availability of products to end consumers.

History

Omkar Pharmachem Limited was founded in 1995. The company was incorporated in 1995.

New support ticket

Explore

Omkar Pharmachem Stock Value

Omkar Pharmachem Company Info

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the industrials sector (5Y.)

What does Omkar Pharmachem do?

Offer & Services

Service & Collaboration

Company & Legal

New support ticket

Explore

Omkar Pharmachem Stock Value

Omkar Pharmachem Company Info

Analyst Price Target The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the industrials sector (5Y.)

What does Omkar Pharmachem do?

Offer & Services

Service & Collaboration

Company & Legal

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.